Cover Page
Cover Page - shares | 9 Months Ended | |
Sep. 30, 2023 | Nov. 01, 2023 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Sep. 30, 2023 | |
Document Transition Report | false | |
Entity File Number | 000-50307 | |
Entity Registrant Name | FormFactor, Inc. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 13-3711155 | |
Entity Address, Address Line One | 7005 Southfront Road | |
Entity Address, City or Town | Livermore | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 94551 | |
City Area Code | 925 | |
Local Phone Number | 290-4000 | |
Title of 12(b) Security | Common stock, $0.001 par value | |
Trading Symbol | FORM | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 77,842,001 | |
Amendment Flag | false | |
Entity Central Index Key | 0001039399 | |
Current Fiscal Year End Date | --12-30 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q3 |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Current assets: | ||
Cash and cash equivalents | $ 108,731 | $ 109,130 |
Marketable securities | 135,693 | 129,006 |
Accounts receivable, net of allowance for credit losses of $500 and $168 | 88,965 | 88,143 |
Inventories, net | 111,626 | 123,157 |
Restricted cash | 1,171 | 1,221 |
Assets held-for-sale | 33,718 | 0 |
Prepaid expenses and other current assets | 26,681 | 23,895 |
Total current assets | 506,585 | 474,552 |
Restricted cash | 2,146 | 2,631 |
Operating lease, right-of-use-assets | 29,824 | 31,362 |
Property, plant and equipment, net of accumulated depreciation | 203,510 | 189,848 |
Goodwill | 200,485 | 211,444 |
Intangibles, net | 13,578 | 26,751 |
Deferred tax assets | 73,572 | 67,646 |
Other assets | 3,267 | 3,994 |
Total assets | 1,032,967 | 1,008,228 |
Current liabilities: | ||
Accounts payable | 61,589 | 69,308 |
Accrued liabilities | 36,487 | 42,115 |
Current portion of term loan, net of unamortized issuance costs | 1,067 | 1,045 |
Deferred revenue | 13,855 | 29,846 |
Liabilities held-for-sale | 8,521 | 0 |
Operating lease liabilities | 8,007 | 7,353 |
Total current liabilities | 129,526 | 149,667 |
Term loan, less current portion, net of unamortized issuance costs | 13,586 | 14,389 |
Deferred tax liabilities | 317 | 2,732 |
Long-term operating lease liabilities | 25,096 | 27,587 |
Deferred grant | 18,000 | 0 |
Other liabilities | 5,754 | 5,568 |
Total liabilities | 192,279 | 199,943 |
Stockholders’ equity: | ||
Common stock, $0.001 par value | 78 | 77 |
Additional paid-in capital | 873,634 | 844,842 |
Accumulated other comprehensive loss | (8,509) | (5,578) |
Accumulated deficit | (24,515) | (31,056) |
Total stockholders’ equity | 840,688 | 808,285 |
Total liabilities and stockholders’ equity | $ 1,032,967 | $ 1,008,228 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Allowance for doubtful accounts | $ 500 | $ 168 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 250,000,000 | 250,000,000 |
Common stock, shares issued (in shares) | 77,839,317 | 76,914,590 |
Common stock, shares outstanding (in shares) | 77,839,317 | 76,914,590 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
Income Statement [Abstract] | ||||
Revenues | $ 171,575 | $ 180,869 | $ 494,939 | $ 581,950 |
Cost of revenues | 102,290 | 118,656 | 304,293 | 331,144 |
Gross profit | 69,285 | 62,213 | 190,646 | 250,806 |
Operating expenses: | ||||
Research and development | 31,014 | 26,549 | 87,599 | 82,000 |
Selling, general and administrative | 35,564 | 31,637 | 101,561 | 97,949 |
Total operating expenses | 66,578 | 58,186 | 189,160 | 179,949 |
Operating income | 2,707 | 4,027 | 1,486 | 70,857 |
Interest income, net | 1,662 | 557 | 4,420 | 684 |
Other income, net | 788 | 1,041 | 1,261 | 1,784 |
Income before income taxes | 5,157 | 5,625 | 7,167 | 73,325 |
Provision for income taxes | 786 | 1,274 | 626 | 8,860 |
Net income | $ 4,371 | $ 4,351 | $ 6,541 | $ 64,465 |
Net income per share: | ||||
Basic (in dollars per share) | $ 0.06 | $ 0.06 | $ 0.08 | $ 0.83 |
Diluted (in dollars per share) | $ 0.06 | $ 0.06 | $ 0.08 | $ 0.82 |
Weighted-average number of shares used in per share calculations: | ||||
Basic (in shares) | 77,571 | 77,245 | 77,265 | 77,796 |
Diluted (in shares) | 78,412 | 77,688 | 77,860 | 78,492 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
Statement of Comprehensive Income [Abstract] | ||||
Net income | $ 4,371 | $ 4,351 | $ 6,541 | $ 64,465 |
Other comprehensive loss, net of tax: | ||||
Translation adjustments | (3,351) | (7,348) | (2,641) | (13,902) |
Unrealized gains (losses) on available-for-sale marketable securities | 283 | (674) | 801 | (2,425) |
Unrealized losses on derivative instruments | (996) | (881) | (1,091) | (123) |
Other comprehensive loss, net of tax: | (4,064) | (8,903) | (2,931) | (16,450) |
Comprehensive income (loss) | $ 307 | $ (4,552) | $ 3,610 | $ 48,015 |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Loss | Accumulated Deficit |
Beginning balance (in shares) at Dec. 25, 2021 | 78,240,506 | ||||
Beginning balance at Dec. 25, 2021 | $ 815,780 | $ 78 | $ 898,945 | $ (1,449) | $ (81,794) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Issuance of common stock under the Employee Stock Purchase Plan (in shares) | 316,861 | ||||
Issuance of common stock under the Employee Stock Purchase Plan | 10,457 | 10,457 | |||
Issuance of common stock pursuant to exercise of options (in shares) | 6,000 | ||||
Issuance of common stock pursuant to exercise of options | 42 | 42 | |||
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax (in shares) | 713,554 | ||||
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax | (15,563) | $ 1 | (15,564) | ||
Purchase of common stock retired through repurchase program (in shares) | 2,011,822 | ||||
Purchase and retirement of common stock through repurchase program | (73,478) | $ (2) | (73,476) | ||
Stock-based compensation | 23,049 | 23,049 | |||
Other comprehensive income (loss) | (16,450) | (16,450) | |||
Net income | 64,465 | 64,465 | |||
Ending balance (in shares) at Sep. 24, 2022 | 77,265,099 | ||||
Ending balance at Sep. 24, 2022 | 808,302 | $ 77 | 843,453 | (17,899) | (17,329) |
Beginning balance (in shares) at Jun. 25, 2022 | 77,194,733 | ||||
Beginning balance at Jun. 25, 2022 | 829,985 | $ 77 | 860,584 | (8,996) | (21,680) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Issuance of common stock under the Employee Stock Purchase Plan (in shares) | 159,219 | ||||
Issuance of common stock under the Employee Stock Purchase Plan | 4,812 | $ 0 | 4,812 | ||
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax (in shares) | 479,478 | ||||
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax | (11,320) | $ 1 | (11,321) | ||
Purchase of common stock retired through repurchase program (in shares) | 568,331 | ||||
Purchase and retirement of common stock through repurchase program | (19,150) | $ (1) | (19,149) | ||
Stock-based compensation | 8,527 | 8,527 | |||
Other comprehensive income (loss) | (8,903) | (8,903) | |||
Net income | 4,351 | 4,351 | |||
Ending balance (in shares) at Sep. 24, 2022 | 77,265,099 | ||||
Ending balance at Sep. 24, 2022 | $ 808,302 | $ 77 | 843,453 | (17,899) | (17,329) |
Beginning balance (in shares) at Dec. 31, 2022 | 76,914,590 | 76,914,590 | |||
Beginning balance at Dec. 31, 2022 | $ 808,285 | $ 77 | 844,842 | (5,578) | (31,056) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Issuance of common stock under the Employee Stock Purchase Plan (in shares) | 363,190 | ||||
Issuance of common stock under the Employee Stock Purchase Plan | 8,822 | 8,822 | |||
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax (in shares) | 561,537 | ||||
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax | (9,349) | $ 1 | (9,350) | ||
Stock-based compensation | 29,320 | 29,320 | |||
Other comprehensive income (loss) | (2,931) | (2,931) | |||
Net income | $ 6,541 | 6,541 | |||
Ending balance (in shares) at Sep. 30, 2023 | 77,839,317 | 77,839,317 | |||
Ending balance at Sep. 30, 2023 | $ 840,688 | $ 78 | 873,634 | (8,509) | (24,515) |
Beginning balance (in shares) at Jul. 01, 2023 | 77,184,012 | ||||
Beginning balance at Jul. 01, 2023 | 834,263 | $ 77 | 867,517 | (4,445) | (28,886) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Issuance of common stock under the Employee Stock Purchase Plan (in shares) | 153,135 | ||||
Issuance of common stock under the Employee Stock Purchase Plan | 3,798 | 3,798 | |||
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax (in shares) | 502,170 | ||||
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax | (8,893) | $ 1 | (8,894) | ||
Stock-based compensation | 11,213 | 11,213 | |||
Other comprehensive income (loss) | (4,064) | (4,064) | |||
Net income | $ 4,371 | 4,371 | |||
Ending balance (in shares) at Sep. 30, 2023 | 77,839,317 | 77,839,317 | |||
Ending balance at Sep. 30, 2023 | $ 840,688 | $ 78 | $ 873,634 | $ (8,509) | $ (24,515) |
CONDENSED CONSOLIDATED STATEM_4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2023 | Sep. 24, 2022 | |
Cash flows from operating activities: | ||
Net income | $ 6,541 | $ 64,465 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation | 22,880 | 21,189 |
Amortization | 6,043 | 7,056 |
Reduction in the carrying amount of right-of-use assets | 5,556 | 5,900 |
Stock-based compensation expense | 29,333 | 21,873 |
Deferred income tax benefit | (6,283) | (6,881) |
Provision for excess and obsolete inventories | 12,566 | 16,078 |
Other adjustments to reconcile net income to net cash provided by operating activities | 1,375 | 4,066 |
Changes in assets and liabilities: | ||
Accounts receivable | (7,796) | 1,654 |
Inventories | (8,910) | (33,023) |
Prepaid expenses and other current assets | (1,761) | (2,016) |
Other assets | 804 | (117) |
Accounts payable | 474 | 17,613 |
Accrued liabilities | (5,268) | (5,035) |
Other liabilities | 467 | 276 |
Deferred revenues | (12,915) | 3,776 |
Deferred grant | 18,000 | |
Operating lease liabilities | (5,754) | (5,826) |
Net cash provided by operating activities | 55,352 | 111,048 |
Cash flows from investing activities: | ||
Acquisition of property, plant and equipment | (46,094) | (39,024) |
Acquisition of business | 0 | 3,350 |
Purchases of marketable securities | (96,913) | (80,249) |
Purchase of promissory note receivable | 0 | (1,000) |
Proceeds from maturities and sales of marketable securities | 93,013 | 71,610 |
Net cash used in investing activities | (49,994) | (52,013) |
Cash flows from financing activities: | ||
Proceeds from issuances of common stock | 8,822 | 10,499 |
Purchase of common stock through stock repurchase program | 0 | (73,478) |
Tax withholdings related to net share settlements of equity awards | (9,349) | (15,564) |
Principal repayments on term loans | (781) | (6,421) |
Net cash used in financing activities | (1,308) | (84,964) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (3,324) | (5,708) |
Net increase (decrease) in cash, cash equivalents and restricted cash | 726 | (31,637) |
Cash, cash equivalents and restricted cash, beginning of period | 112,982 | 155,342 |
Cash, cash equivalents and restricted cash, end of period | 113,708 | 123,705 |
Non-cash investing and financing activities: | ||
Increase (decrease) in accounts payable and accrued liabilities related to property, plant and equipment purchases | (6,222) | 341 |
Operating lease, right-of-use assets obtained in exchange for lease obligations | 4,728 | 3,457 |
Supplemental disclosure of cash flow information: | ||
Cash paid for income taxes, net | 12,064 | 9,911 |
Cash paid for interest | 317 | 455 |
Operating cash outflows from operating leases | 6,836 | 6,670 |
Reconciliation of cash, cash equivalents and restricted cash: | ||
Cash and cash equivalents | 108,731 | 120,602 |
Restricted cash, current | 1,171 | 1,263 |
Restricted cash, non-current | 2,146 | 1,840 |
Cash and cash equivalents included in Assets held-for-sale | 1,660 | 0 |
Total cash, cash equivalents and restricted cash | $ 113,708 | $ 123,705 |
Basis of Presentation and Signi
Basis of Presentation and Significant Accounting Policies | 9 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation and Significant Accounting Policies | Basis of Presentation and Significant Accounting Policies Basis of Presentation The accompanying condensed consolidated financial information of FormFactor, Inc. is unaudited and has been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). However, such information reflects all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods. The condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and the notes thereto included in our 2022 Annual Report on Form 10-K filed with the SEC on February 24, 2023. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the full year. Fiscal Year We operate on a 52/53 week fiscal year, whereby the fiscal year ends on the last Saturday of December. Fiscal 2023 and 2022 contain 52 weeks and 53 weeks, respectively, and the nine months ended September 30, 2023 and September 24, 2022 each contained 39 weeks. Fiscal 2023 will end on December 30, 2023. Significant Accounting Policies Our significant accounting policies have not changed during the nine months ended September 30, 2023 from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022, except for: Government Assistance In January 2023, we received $18.0 million in cash from a California Competes Grant (the “Grant”) awarded from the California Governor’s Office of Business and Economic Development. The Grant requires FormFactor to create and maintain full-time jobs and make significant infrastructure investments within California over a 5-year term. If we do not meet the requirements of the Grant, we will be required to repay all or a portion of the Grant. The Grant is included in our Condensed Consolidated Balance Sheets within Deferred grant and we have elected to recognize the Grant when earned as an offset to Cost of revenues and Operating expenses within our Condensed Consolidated Statements of Income. We have presented the proceeds from the Grant as cash provided by operating activities within our Condensed Consolidated Statements of Cash Flows as the Grant is to offset operations. New Accounting Pronouncements Reference Rate Reform In March 2020, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides temporary optional expedients and exceptions for applying GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Interbank Offered Rate (“LIBOR“) or another reference rate expected to be discontinued. In December 2022, the FASB issued ASU 2022-06, “Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848,” extending the relief offered in Topic 848 from December 31, 2022 to December 31, 2024, after which entities will no longer be permitted to apply the optional expedients in Topic 848. In May 2023, the Company entered into a rate replacement amendment to its credit facility loan agreement to replace LIBOR with the Secured Overnight Financing Rate (“SOFR”) and concurrently signed an amendment to modify the floating rate option on its interest rate swap to match that of the debt. The Company applied practical expedients provided in Topic 848 allowing the modified instrument to be accounted for and presented in the same manner as the instrument existing before the modification. These modifications had no significant impact on our financial statements. Refer to Note 7, Debt, for further information regarding the terms of the credit facility loan agreement and interest rate swap agreement. Reclassifications Certain immaterial reclassifications were made to the prior year financial statements to conform to the current year presentation. |
Concentration of Credit and Oth
Concentration of Credit and Other Risks | 9 Months Ended |
Sep. 30, 2023 | |
Risks and Uncertainties [Abstract] | |
Concentration of Credit and Other Risks | Concentration of Credit and Other Risks Each of the following customers accounted for 10% or more of our revenues for the periods indicated: Three Months Ended Nine Months Ended September 30, September 24, September 30, September 24, Intel Corporation 17.1 % 17.0 % 17.2 % 19.7 % Samsung Electronics., LTD. 11.2 % * * * SK Hynix Inc. * 10.7 % * * 28.3 % 27.7 % 17.2 % 19.7 % |
Inventories, net
Inventories, net | 9 Months Ended |
Sep. 30, 2023 | |
Inventory Disclosure [Abstract] | |
Inventories, net | Inventories, net Inventories are stated at the lower of cost (principally standard cost, which approximates actual cost on a first in, first out basis) or net realizable value. Inventories, net, consisted of the following (in thousands): September 30, December 31, Raw materials $ 50,641 $ 55,726 Work-in-progress 40,150 46,067 Finished goods 20,835 21,364 $ 111,626 $ 123,157 |
Assets Held-For-Sale Divestitur
Assets Held-For-Sale Divestiture | 9 Months Ended |
Sep. 30, 2023 | |
Asset Retirement Obligation Disclosure [Abstract] | |
Assets Held-For-Sale Divestiture | Assets Held-For-Sale Divestiture On September 18, 2023, the Company announced entry into a definitive agreement to sell its FRT Metrology (“FRT”) business to Camtek Ltd. (“Camtek”) for $100 million in cash, subject to customary purchase price adjustments. The Company acquired FRT in fiscal 2019 for total consideration of $24.4 million, net of cash acquired. Headquartered in Bergisch Gladbach, Germany, FRT is a leading supplier of high-precision metrology solutions for the Advanced Packaging and Silicon Carbide markets, and is part of our Systems segment. The related assets and liabilities have been classified as held-for-sale in the Company’s consolidated balance sheet and measured at the lower of their carrying amount or fair value less cost to sell. We did not record an impairment from this event. The planned disposition of the FRT business did not meet the criteria to be classified as a discontinued operation in the Company’s financial statements since the disposition did not represent a strategic shift that had, or will have, a major effect on the Company’s operations and financial results. The components of held-for-sale assets and liabilities at September 30, 2023 were as follows (in thousands): Assets held-for-sale Accounts receivable, net of allowance for credit losses $ 5,491 Inventories, net 7,092 Other current assets 2,131 Intangibles, net 7,069 Goodwill 10,668 Other assets 1,267 Total assets held-for-sale $ 33,718 Liabilities held-for-sale Current liabilities $ 6,045 Other liabilities 2,476 Total liabilities held-for-sale $ 8,521 On November 1, 2023, we closed on the sale of FRT to Camtek and received cash proceeds of $103.8 million after preliminary adjustments with respect to cash, indebtedness, and working capital. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets | 9 Months Ended |
Sep. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Intangible Assets | Goodwill and Intangible Assets Goodwill by reportable segment was as follows (in thousands): Probe Cards Systems Total Goodwill, as of December 25, 2021 $ 178,424 $ 33,875 $ 212,299 Addition - Woburn Acquisition — 550 550 Foreign currency translation — (1,405) (1,405) Goodwill, as of December 31, 2022 178,424 33,020 211,444 Reclassification - Assets held-for-sale — (10,668) (10,668) Foreign currency translation — (291) (291) Goodwill, as of September 30, 2023 $ 178,424 $ 22,061 $ 200,485 We have not recorded goodwill impairments for the nine months ended September 30, 2023. Intangible assets were as follows (in thousands): September 30, 2023 December 31, 2022 Intangible Assets Gross Accumulated Net Gross Accumulated Net Existing developed technologies $ 159,115 $ 147,517 $ 11,598 $ 171,441 $ 151,212 $ 20,229 Customer relationships 47,877 46,388 1,489 50,912 45,003 5,909 Trade name 7,754 7,663 91 7,972 7,759 213 In-process research and development 400 — 400 400 — 400 $ 215,146 $ 201,568 $ 13,578 $ 230,725 $ 203,974 $ 26,751 In the current quarter, $7.1 million of net Intangible assets were reclassified to Assets held-for-sale as described in Note 4 , Assets Held-For-Sale Divestiture. Amortization expense was included in our Condensed Consolidated Statements of Income as follows (in thousands): Three Months Ended Nine Months Ended September 30, September 24, September 30, September 24, Cost of revenues $ 837 $ 824 $ 2,506 $ 2,420 Selling, general and administrative 440 1,530 3,537 4,636 $ 1,277 $ 2,354 $ 6,043 $ 7,056 The estimated future amortization of definite-lived intangible assets, excluding in-process research and development, is as follows (in thousands): Fiscal Year Amount Remainder of 2023 $ 640 2024 2,561 2025 2,330 2026 1,630 2027 1,630 Thereafter 4,387 $ 13,178 |
Accrued Liabilities
Accrued Liabilities | 9 Months Ended |
Sep. 30, 2023 | |
Payables and Accruals [Abstract] | |
Accrued Liabilities | Accrued Liabilities Accrued liabilities consisted of the following (in thousands): September 30, December 31, Accrued compensation and benefits $ 22,684 $ 15,864 Accrued warranty 4,984 4,199 Employee stock purchase plan contributions withheld 1,576 4,585 Accrued income and other taxes 2,761 12,817 Accrued restructuring charges 29 1,249 Other accrued expenses 4,453 3,401 $ 36,487 $ 42,115 |
Debt
Debt | 9 Months Ended |
Sep. 30, 2023 | |
Debt Disclosure [Abstract] | |
Debt | Debt On June 22, 2020, we entered into an $18.0 million 15-year credit facility loan agreement (the “Building Term Loan”) with MUFG Union Bank, National Association (“Union Bank”). The proceeds of the Building Term Loan were used to purchase a building adjacent to our leased facilities in Livermore, California. On May 19, 2023, we amended the Building Term Loan, replacing the benchmark reference rate LIBOR with SOFR, with no change to the amount or timing of contractual cash flows. The Building Term Loan bears interest at a rate equal to the applicable SOFR rate, plus 0.1148%, plus 1.75% per annum. Interest payments are payable in monthly installments over a fifteen-year period. The interest rate at September 30, 2023 was 7.19%. On March 17, 2020, we entered into an interest rate swap agreement with Union Bank to hedge the interest payment on the Building Term Loan for the notional amount of $18.0 million. As future levels of LIBOR over the life of the loan were uncertain, we entered into this interest-rate swap agreement to hedge the exposure in interest rate risks associated with movement in LIBOR rates. By entering into the agreement, we converted a floating-rate interest at one-month LIBOR plus 1.75% into a fixed-rate interest at 2.75%. This agreement was amended on May 19, 2023 to replace the benchmark reference rate LIBOR with SOFR to match the Building Term Loan agreement (as amended). After the amendment, the interest rate swap continues to convert our floating-rate interest into a fixed-rate at 2.75%. |
Restructuring Charges
Restructuring Charges | 9 Months Ended |
Sep. 30, 2023 | |
Restructuring and Related Activities [Abstract] | |
Restructuring Charges | Restructuring Charges 2022 Restructuring Plan On October 25, 2022, we adopted a restructuring plan (“2022 restructuring plan”) to align our cost structure with reduced demand levels, by streamlining and improving the efficiency and business effectiveness of our operations. This plan included lowering headcount by approximately 13% of our workforce. The Company has recognized 2022 restructuring plan charges of approximately $8.1 million for severance and employee-related costs, including $0.3 million for stock-based compensation, with $7.1 million within the Probe Cards segment, $0.5 million within the Systems segment, and $0.5 million within Corporate. We do not expect to incur additional material costs related to the 2022 restructuring plan. 2021 Restructuring Plan On September 25, 2021, we adopted restructuring plans (“2021 restructuring plans”) to improve our business effectiveness and streamline our operations by consolidating certain manufacturing facilities for both the Probe Cards segment and the Systems segment. This included plans to consolidate or relocate certain leased locations in the United States to other locations in the United States, Germany and Asia. As a result of these changes to certain work locations, we have incurred personnel related costs to sever, relocate, or retain select employees. Additionally, as part of these plans we have undertaken actions to adjust capacity for certain product offerings, which included contract termination costs to satisfy contract obligations. The Company has recognized 2021 restructuring plans charges of approximately $13.3 million, with $10.1 million within the Probe Cards segment and $3.2 million within the Systems segment, which were comprised of $1.4 million of severance and employee-related costs, $2.0 million in contract and lease termination costs, $9.4 million in inventory impairments and other inventory related costs, and $0.5 million of costs related to impairment of leasehold improvements, facility exits and fixed asset related costs. We do not expect additional material costs related to the 2021 restructuring plan. Total restructuring charges for both the 2022 and 2021 restructuring plans included in our Condensed Consolidated Statements of Income were as follows (in thousands): Three Months Ended September 30, 2023 September 24, 2022 Probe Cards Systems Total Probe Cards Systems Total Cost of revenues $ — $ — $ — $ 5,928 $ 132 $ 6,060 Research and development — — — 38 29 67 Selling, general and administrative — — — — 47 47 $ — $ — $ — $ 5,966 $ 208 $ 6,174 Nine Months Ended September 30, 2023 September 24, 2022 Probe Cards Systems Total Probe Cards Systems Total Cost of revenues $ 106 $ 251 $ 357 $ 6,194 $ 459 $ 6,653 Research and development 182 109 291 38 228 266 Selling, general and administrative 1,069 118 1,187 3 146 149 $ 1,357 $ 478 $ 1,835 $ 6,235 $ 833 $ 7,068 Changes to the restructuring accrual in the nine months ended September 30, 2023 were as follows (in thousands): Employee Severance Stock-based Compensation Inventory Contract Total December 31, 2022 $ 1,249 $ — $ — $ — $ 1,249 Restructuring charges 917 295 390 233 1,835 Cash payments (2,137) — (89) (233) (2,459) Non-cash settlement — (295) (301) — (596) September 30, 2023 $ 29 $ — $ — $ — $ 29 |
Fair Value and Derivative Instr
Fair Value and Derivative Instruments | 9 Months Ended |
Sep. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value and Derivative Instruments | Fair Value and Derivative Instruments Whenever possible, the fair values of our financial assets and liabilities are determined using quoted market prices of identical securities or quoted market prices of similar securities from active markets. The three levels of inputs that may be used to measure fair value are as follows: • Level 1 valuations are obtained from real-time quotes for transactions in active exchange markets involving identical securities; • Level 2 valuations utilize significant observable inputs, such as quoted prices for similar assets or liabilities, quoted prices near the reporting date in markets that are less active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and • Level 3 valuations utilize unobservable inputs to the valuation methodology and include our own data about assumptions market participants would use in pricing the asset or liability based on the best information available under the circumstances. We did not have any transfers of assets or liabilities measured at fair value on a recurring basis to or from Level 1, Level 2 or Level 3 during the three and nine months ended September 30, 2023 or the year ended December 31, 2022. The carrying values of Cash, Accounts receivable, net, Restricted cash, Prepaid expenses and other current assets, Accounts payable, and Accrued liabilities approximate fair value due to their short maturities. No changes were made to our valuation techniques during the first nine months of fiscal 2023. Assets and Liabilities Measured at Fair Value on a Recurring Basis Assets and liabilities measured at fair value on a recurring basis were as follows (in thousands): September 30, 2023 Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 26,936 $ — $ — $ 26,936 U.S. treasuries 2,290 — — 2,290 Commercial paper — 1,790 — 1,790 29,226 1,790 — 31,016 Marketable securities: U.S. treasuries 46,403 — — 46,403 Certificates of deposit — 238 — 238 U.S. agency securities — 12,141 — 12,141 Corporate bonds — 61,106 — 61,106 Commercial paper — 15,805 — 15,805 46,403 89,290 — 135,693 Promissory note receivable — — 922 922 Interest rate swap derivative contract — 2,536 — 2,536 Total assets $ 75,629 $ 93,616 $ 922 $ 170,167 Liabilities: Foreign exchange derivative contracts $ — $ (781) $ — $ (781) Total liabilities $ — $ (781) $ — $ (781) December 31, 2022 Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 21,279 $ — $ — $ 21,279 Commercial paper — 4,969 — 4,969 U.S. agency securities — 996 — 996 21,279 5,965 — 27,244 Marketable securities: U.S. treasuries 25,019 — — 25,019 Certificates of deposit — 706 — 706 U.S. agency securities — 11,045 — 11,045 Corporate bonds — 67,396 — 67,396 Commercial paper — 24,840 — 24,840 25,019 103,987 — 129,006 Foreign exchange derivative contracts — 664 — 664 Promissory note receivable — — 943 943 Interest rate swap derivative contract — 2,374 — 2,374 Total assets $ 46,298 $ 112,990 $ 943 $ 160,231 Liabilities: Foreign exchange derivative contracts $ — $ (193) $ — $ (193) Total liabilities $ — $ (193) $ — $ (193) Cash Equivalents The fair value of our cash equivalents is determined based on quoted market prices for similar or identical securities. Marketable Securities We classify our marketable securities as available-for-sale and value them utilizing a market approach. Our investments are priced by pricing vendors who provide observable inputs for their pricing without applying significant judgment. Broker pricing is used mainly when a quoted price is not available, the investment is not priced by our pricing vendors or when a broker price is more reflective of fair value. Our broker-priced investments are categorized as Level 2 investments because fair value is based on similar assets without applying significant judgments. In addition, all investments have a sufficient trading volume to demonstrate that the fair value is appropriate. Unrealized gains and losses were immaterial and were recorded as a component of Accumulated other comprehensive loss in our Condensed Consolidated Balance Sheets. We did not have any other-than-temporary unrealized gains or losses at either period end included in these financial statements. Interest Rate Swap The fair value of our interest rate swap contract is determined at the end of each reporting period based on valuation models that use interest rate yield curves as inputs. For accounting purposes, our interest rate swap contract qualifies for, and is designated as a cash flow hedge. The hedged risk is the interest rate exposure to changes in interest payments attributable to changes in our variable-rate interest over the interest rate swap term. The changes in cash flows of the interest rate swap are expected to exactly offset changes in cash flows of the variable-rate debt. Cash settlements, in the form of cash payments or cash receipts, of the interest rate swap, in the form of cash payments or cash receipts, are recognized as a component of interest expense. The cash flows associated with the interest rate swaps are reported in Net cash provided by operating activities in our Condensed Consolidated Statements of Cash Flows and the fair value of the interest rate swap contracts are recorded within Prepaid expenses and other current assets and Other assets in our Condensed Consolidated Balance Sheets. Foreign Exchange Derivative Contracts We operate and sell our products in various global markets. As a result, we are exposed to changes in foreign currency exchange rates. We utilize foreign currency forward contracts to hedge against future movements in foreign exchange rates that affect certain existing foreign currency denominated assets and liabilities and forecasted foreign currency revenue and expense transactions. Under this program, our strategy is to have increases or decreases in our foreign currency exposures mitigated by gains or losses on the foreign currency forward contracts in order to mitigate the risks and volatility associated with foreign currency transaction gains or losses. We do not use derivative financial instruments for speculative or trading purposes. For accounting purposes, certain of our foreign currency forward contracts are not designated as hedging instruments and, accordingly, we record the fair value of these contracts as of the end of our reporting period in our Condensed Consolidated Balance Sheets with changes in fair value recorded within Other income, net in our Condensed Consolidated Statement of Income for both realized and unrealized gains and losses. Certain of our foreign currency forward contracts are designated as cash flow hedges, and, accordingly, we record the fair value of these contracts as of the end of our reporting period in our Condensed Consolidated Balance Sheets with changes in fair value recorded as a component of Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings, and in the same line item on the Condensed Consolidated Statements of Income as the impact of the hedge transaction. The fair value of our foreign exchange derivative contracts was determined based on current foreign currency exchange rates and forward points. All of our foreign exchange derivative contracts outstanding at September 30, 2023 will mature by the third quarter of fiscal 2024. The following table provides information about our foreign currency forward contracts outstanding as of September 30, 2023 (in thousands): Currency Contract Position Contract Amount Contract Amount Euro Dollar Buy 20,312 $ 22,427 Euro Dollar Sell 3,576 3,786 Japanese Yen Sell 2,759,293 18,535 Korean Won Buy 1,520,865 1,133 Taiwan Dollar Sell 59,367 1,839 Our foreign currency contracts are classified within Level 2 of the fair value hierarchy as they are valued using pricing models that utilize observable market inputs. We measure and report our non-financial assets such as Property, plant and equipment, Goodwill and Intangible assets at fair value on a non-recurring basis if we determine these assets to be impaired or in the period when we make a business acquisition. Other than as discussed in Note 8, Restructuring Charges, |
Warranty
Warranty | 9 Months Ended |
Sep. 30, 2023 | |
Product Warranties Disclosures [Abstract] | |
Warranty | Warranty We offer warranties on certain products and record a liability for the estimated future costs associated with warranty claims at the time revenue is recognized. The warranty liability is based upon historical experience and our estimate of the level of future costs. While we engage in product quality programs and processes, our warranty obligation is affected by product failure rates, material usage and service delivery costs. We regularly monitor product returns for warranty and maintain a reserve for the related expenses based upon our historical experience and any specifically identified failures. As we sell new products to our customers, we must exercise considerable judgment in estimating the expected failure rates. This estimating process is based on historical experience of similar products, as well as various other assumptions that we believe to be reasonable under the circumstances. We provide for the estimated cost of product warranties at the time revenue is recognized as a component of Cost of revenues in our Condensed Consolidated Statement of Income. Changes in our warranty liability were as follows (in thousands): Nine Months Ended September 30, September 24, Balance at beginning of period $ 4,199 $ 2,805 Accruals 6,426 5,653 Settlements (5,535) (4,652) Reclassification - Liabilities held-for-sale (106) — Balance at end of period $ 4,984 $ 3,806 |
Property, Plant, and Equipment,
Property, Plant, and Equipment, net | 9 Months Ended |
Sep. 30, 2023 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment, net | Property, Plant and Equipment, net Property, plant and equipment, net consisted of the following (in thousands): September 30, December 31, Land $ 17,136 $ 17,136 Building and building improvements 44,452 44,932 Machinery and equipment 286,033 276,180 Computer equipment and software 46,968 45,813 Furniture and fixtures 7,471 7,540 Leasehold improvements 90,813 86,500 Sub-total 492,873 478,101 Less: Accumulated depreciation and amortization (353,796) (335,711) Net, property, plant and equipment 139,077 142,390 Construction-in-process 64,433 47,458 Total $ 203,510 $ 189,848 In the current quarter, $0.9 million of net Property, plant and equipment were reclassified to Assets held-for-sale as described in Note 4 , Assets Held-For-Sale Divestiture. |
Stockholders_ Equity and Stock-
Stockholders’ Equity and Stock-Based Compensation | 3 Months Ended |
Sep. 30, 2023 | |
Equity [Abstract] | |
Stockholders’ Equity and Stock-Based Compensation | Stockholders’ Equity and Stock-Based Compensation Common Stock Repurchase Programs On October 26, 2020, our Board of Directors authorized a two On May 20, 2022, our Board of Directors authorized an additional program to repurchase up to $75 million of outstanding common stock, also with the primary purpose to offset potential dilution from issuances of common stock under our stock-based compensation programs. The share repurchase program will expire on May 20, 2024. During the nine months ended September 30, 2023, we did not repurchase any common stock. As of September 30, 2023, $18.6 million remained available for future repurchases. On October 30, 2023, our Board of Directors authorized a new two Our policy related to repurchases of our common stock is to charge the excess of cost over par value to additional paid-in capital once the shares are retired. The net share repurchases are subject to a 1% excise tax under the Inflation Reduction Act. The excise tax incurred reduces the amount available under the repurchase programs, as applicable, and is included in the cost of shares repurchased in the Condensed Consolidated Statement of Stockholders Equity. All repurchases were made in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended. Restricted Stock Units Restricted stock unit (“RSU”) activity under our equity incentive plan was as follows: Units Weighted Average Grant Date Fair Value RSUs at December 31, 2022 2,227,081 $ 35.28 Awards granted 1,402,715 33.84 Awards vested (830,549) 33.56 Awards forfeited (336,753) 30.14 RSUs at September 30, 2023 2,462,494 35.74 Performance Restricted Stock Units We may grant Performance RSUs (“PRSUs”) to certain executives, which vest based upon us achieving certain market performance criteria. On August 7, 2023, we granted 172,680 PRSUs to certain senior executives for a total grant date fair value of $8.6 million which will be recognized ratably over the requisite service period. The performance criteria are based on Total Shareholder Returns (“TSR”) for the period of July 1, 2023 - June 30, 2026, relative to the TSR of the companies identified as being part of the S&P Semiconductors Select Industry Index (FormFactor peer companies) as of the grant date. Of the 258,600 PRSUs granted in fiscal 2020, none of the 191,400 outstanding PRSU awards vested in 2023, at the end of the requisite service period, as the TSR performance was not met. PRSUs are included as part of the RSU activity above. Employee Stock Purchase Plan Information related to activity under our Employee Stock Purchase Plan (“ESPP”) was as follows: Nine Months Ended September 30, 2023 Shares issued 363,190 Weighted average per share purchase price $ 24.29 Weighted average per share discount from the fair value of our common stock on the date of issuance $ 7.65 Stock-Based Compensation Stock-based compensation was included in our Condensed Consolidated Statements of Income as follows (in thousands): Three Months Ended Nine Months Ended September 30, September 24, September 30, September 24, Cost of revenues $ 1,376 $ 1,022 $ 4,801 $ 2,834 Research and development 3,173 2,027 7,908 5,708 Selling, general and administrative 6,290 4,946 16,624 13,331 Total stock-based compensation $ 10,839 $ 7,995 $ 29,333 $ 21,873 Unrecognized Compensation Costs At September 30, 2023, the unrecognized stock-based compensation was as follows (dollars in thousands): Unrecognized Expense Average Expected Restricted stock units $ 58,985 2.21 Performance restricted stock units 14,667 2.20 Employee stock purchase plan 1,498 0.25 Total unrecognized stock-based compensation expense $ 75,150 2.17 |
Net Income per Share
Net Income per Share | 9 Months Ended |
Sep. 30, 2023 | |
Earnings Per Share [Abstract] | |
Net Income per Share | Net Income per Share The following table reconciles the shares used in calculating basic net income per share and diluted net income per share (in thousands): Three Months Ended Nine Months Ended September 30, September 24, September 30, September 24, Weighted-average shares used in computing basic net income per share 77,571 77,245 77,265 77,796 Add potentially dilutive securities 841 443 595 696 Weighted-average shares used in computing diluted net income per share 78,412 77,688 77,860 78,492 Securities not included as they would have been antidilutive 172 897 94 266 |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Sep. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Leases See Note 15, Leases . Contractual Obligations and Commitments Our contractual obligations and commitments have not materially changed as of September 30, 2023 from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022. Legal Matters From time to time, we are subject to legal proceedings and claims in the ordinary course of business, the outcomes of which cannot be estimated with certainty. Our ability to estimate the outcomes may change in the near term and the effect of any such change could have a material adverse effect on our financial position, results of operations or cash flows. |
Leases
Leases | 9 Months Ended |
Sep. 30, 2023 | |
Leases [Abstract] | |
Leases | LeasesWe lease real estate space under non-cancelable operating lease agreements for commercial and industrial space, as well as for a portion of our corporate headquarters located in Livermore, California. Our leases have remaining terms of 1 to 6 years, and some leases include options to extend up to 20 years. We also have operating leases for automobiles with remaining lease terms of 1 year. We did not include any of our renewal options in our lease terms for calculating our lease liability as the renewal options allow us to maintain operational flexibility and we are not reasonably certain we will exercise these options at this time. The weighted-average remaining lease term for our operating leases was 5 years as of September 30, 2023 and the weighted-average discount rate was 4.39%. The components of lease expense were as follows (in thousands): Three Months Ended Nine Months Ended September 30, September 24, September 30, September 24, Lease expense: Operating lease expense $ 2,157 $ 2,118 $ 6,233 $ 6,522 Short-term lease expense 126 135 419 251 Variable lease expense 625 590 1,854 1,725 $ 2,908 $ 2,843 $ 8,506 $ 8,498 Future minimum payments under our non-cancelable operating leases were as follows as of September 30, 2023 (in thousands): Fiscal Year Amount Remainder of 2023 $ 2,175 2024 8,773 2025 8,670 2026 7,151 2027 6,734 Thereafter 3,541 Total minimum lease payments 37,044 Less: interest (3,941) Present value of net minimum lease payments 33,103 Less: current portion (8,007) Total long-term operating lease liabilities $ 25,096 |
Revenue
Revenue | 9 Months Ended |
Sep. 30, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | Revenue Transaction price allocated to the remaining performance obligations: On September 30, 2023, we had $13.8 million of remaining performance obligations, which were comprised of deferred service contracts and extended warranty contracts and contracts with overtime revenue recognition that are not yet delivered. We expect to recognize approximately 23.2% of our remaining performance obligations as revenue in the remainder of fiscal 2023, approximately 66.7% in fiscal 2024, and approximately 10.1% in fiscal 2025 and thereafter. The foregoing excludes the value of other remaining performance obligations as they have original durations of one year or less, and also excludes information about variable consideration allocated entirely to a wholly unsatisfied performance obligation. Contract balances: The timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable is recorded at the invoiced amount, net of an allowance for credit losses. A receivable is recognized in the period we deliver goods or provide services or when our right to consideration is unconditional. A contract asset is recorded when we have performed under the contract but our right to consideration is conditional on something other than the passage of time. Contract assets as of September 30, 2023 and December 31, 2022 were $2.9 million and $1.9 million, respectively, and are reported on the Condensed Consolidated Balance Sheets as a component of Prepaid expenses and other current assets. Contract liabilities include payments received and payments due in advance of performance under a contract and are satisfied as the associated revenue is recognized. Contract liabilities are reported on the Condensed Consolidated Balance Sheets at the end of each reporting period as a component of Deferred revenue, Assets held-for-sale, and Other liabilities. Contract liabilities as of September 30, 2023 and December 31, 2022 were $18.0 million and $30.9 million, respectively. During the nine months ended September 30, 2023, we recognized $26.0 million of revenue that was included in contract liabilities as of December 31, 2022. Costs to obtain a contract: We generally expense sales commissions when incurred as a component of Selling, general and administrative expense, as the amortization period is typically less than one year. Revenue by category: Refer to Note 17, Operating Segments and Enterprise-Wide Information |
Operating Segments and Enterpri
Operating Segments and Enterprise-Wide Information | 9 Months Ended |
Sep. 30, 2023 | |
Segment Reporting [Abstract] | |
Operating Segments and Enterprise-Wide Information | Operating Segments and Enterprise-Wide Information Our chief operating decision maker (“CODM”) is our Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire company. We operate in two reportable segments consisting of the Probe Cards segment and the Systems segment. The following table summarizes the operating results by reportable segment (dollars in thousands): Three Months Ended September 30, 2023 September 24, 2022 Probe Cards Systems Corporate and Other Total Probe Cards Systems Corporate and Other Total Revenues $ 128,339 $ 43,236 $ — $ 171,575 $ 139,365 $ 41,504 $ — $ 180,869 Gross profit 49,383 22,396 (2,494) 69,285 48,252 22,284 (8,323) 62,213 Gross margin 38.5 % 51.8 % 40.4 % 34.6 % 53.7 % 34.4 % Nine Months Ended September 30, 2023 September 24, 2022 Probe Cards Systems Corporate and Other Total Probe Cards Systems Corporate and Other Total Revenues $ 370,970 $ 123,969 $ — $ 494,939 $ 467,056 $ 114,894 $ — $ 581,950 Gross profit 135,118 64,266 (8,738) 190,646 203,874 59,967 (13,035) 250,806 Gross margin 36.4 % 51.8 % 38.5 % 43.7 % 52.2 % 43.1 % Operating results provide useful information to our management for assessment of our performance and results of operations. Certain components of our operating results are utilized to determine executive compensation along with other measures. Corporate and Other includes unallocated expenses relating to amortization of intangible assets, inventory and fixed asset fair value adjustments due to acquisitions, share-based compensation, divestiture related expenses, and restructuring charges which are not used in evaluating the results of, or in allocating resources to, our reportable segments. Certain revenue category information by reportable segment was as follows (in thousands): Three Months Ended September 30, 2023 September 24, 2022 Probe Cards Systems Total Probe Cards Systems Total Market: Foundry & Logic $ 96,366 $ — $ 96,366 $ 90,605 $ — $ 90,605 DRAM 27,478 — 27,478 34,922 — 34,922 Flash 4,495 — 4,495 13,838 — 13,838 Systems — 43,236 43,236 — 41,504 41,504 Total $ 128,339 $ 43,236 $ 171,575 $ 139,365 $ 41,504 $ 180,869 Timing of revenue recognition: Products transferred at a point in time $ 127,731 $ 41,776 $ 169,507 $ 138,602 $ 37,842 $ 176,444 Products and services transferred over time 608 1,460 2,068 763 3,662 4,425 Total $ 128,339 $ 43,236 $ 171,575 $ 139,365 $ 41,504 $ 180,869 Geographical region: United States $ 31,182 $ 12,543 $ 43,725 $ 25,909 $ 12,180 $ 38,089 Taiwan 39,155 3,820 42,975 32,227 4,611 36,838 South Korea 31,805 3,270 35,075 28,118 819 28,937 China 10,779 10,971 21,750 27,973 8,755 36,728 Europe 2,583 6,713 9,296 3,682 8,116 11,798 Japan 2,976 3,988 6,964 4,533 3,159 7,692 Malaysia 5,778 186 5,964 6,272 237 6,509 Singapore 2,752 925 3,677 7,983 2,374 10,357 Rest of the world 1,329 820 2,149 2,668 1,253 3,921 Total $ 128,339 $ 43,236 $ 171,575 $ 139,365 $ 41,504 $ 180,869 Nine Months Ended September 30, 2023 September 24, 2022 Probe Cards Systems Total Probe Cards Systems Total Market: Foundry & Logic $ 279,895 $ — $ 279,895 $ 327,106 $ — $ 327,106 DRAM 77,832 — 77,832 106,202 — 106,202 Flash 13,243 — 13,243 33,748 — 33,748 Systems — 123,969 123,969 — 114,894 114,894 Total $ 370,970 $ 123,969 $ 494,939 $ 467,056 $ 114,894 $ 581,950 Timing of revenue recognition: Products transferred at a point in time $ 368,939 $ 116,981 $ 485,920 $ 464,139 $ 106,339 $ 570,478 Products and services transferred over time 2,031 6,988 9,019 2,917 8,555 11,472 Total $ 370,970 $ 123,969 $ 494,939 $ 467,056 $ 114,894 $ 581,950 Geographical region: United States $ 86,954 $ 37,175 $ 124,129 $ 67,424 $ 27,554 $ 94,978 Taiwan 103,368 9,448 112,816 119,937 19,990 139,927 South Korea 77,832 5,881 83,713 80,417 4,776 85,193 China 45,771 26,586 72,357 101,342 23,520 124,862 Europe 8,424 21,114 29,538 9,888 18,396 28,284 Japan 14,014 11,859 25,873 16,034 10,977 27,011 Malaysia 22,279 1,632 23,911 43,946 1,006 44,952 Singapore 7,670 4,170 11,840 23,398 4,963 28,361 Rest of the world 4,658 6,104 10,762 4,670 3,712 8,382 Total $ 370,970 $ 123,969 $ 494,939 $ 467,056 $ 114,894 $ 581,950 |
Basis of Presentation and Sig_2
Basis of Presentation and Significant Accounting Policies (Policies) | 9 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of PresentationThe accompanying condensed consolidated financial information of FormFactor, Inc. is unaudited and has been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). However, such information reflects all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods. The condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and the notes thereto included in our 2022 Annual Report on Form 10-K filed with the SEC on February 24, 2023. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the full year. |
Fiscal Year | Fiscal Year We operate on a 52/53 week fiscal year, whereby the fiscal year ends on the last Saturday of December. Fiscal 2023 and 2022 contain 52 weeks and 53 weeks, respectively, and the nine months ended September 30, 2023 and September 24, 2022 each contained 39 weeks. Fiscal 2023 will end on December 30, 2023. |
Fair Value | Whenever possible, the fair values of our financial assets and liabilities are determined using quoted market prices of identical securities or quoted market prices of similar securities from active markets. The three levels of inputs that may be used to measure fair value are as follows: • Level 1 valuations are obtained from real-time quotes for transactions in active exchange markets involving identical securities; • Level 2 valuations utilize significant observable inputs, such as quoted prices for similar assets or liabilities, quoted prices near the reporting date in markets that are less active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and • Level 3 valuations utilize unobservable inputs to the valuation methodology and include our own data about assumptions market participants would use in pricing the asset or liability based on the best information available under the circumstances. We did not have any transfers of assets or liabilities measured at fair value on a recurring basis to or from Level 1, Level 2 or Level 3 during the three and nine months ended September 30, 2023 or the year ended December 31, 2022. The carrying values of Cash, Accounts receivable, net, Restricted cash, Prepaid expenses and other current assets, Accounts payable, and Accrued liabilities approximate fair value due to their short maturities. No changes were made to our valuation techniques during the first nine months of fiscal 2023. |
Concentration of Credit and O_2
Concentration of Credit and Other Risks (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Risks and Uncertainties [Abstract] | |
Schedule of Customer Percentage of Revenue | Each of the following customers accounted for 10% or more of our revenues for the periods indicated: Three Months Ended Nine Months Ended September 30, September 24, September 30, September 24, Intel Corporation 17.1 % 17.0 % 17.2 % 19.7 % Samsung Electronics., LTD. 11.2 % * * * SK Hynix Inc. * 10.7 % * * 28.3 % 27.7 % 17.2 % 19.7 % |
Inventories, net (Tables)
Inventories, net (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventory Components | Inventories, net, consisted of the following (in thousands): September 30, December 31, Raw materials $ 50,641 $ 55,726 Work-in-progress 40,150 46,067 Finished goods 20,835 21,364 $ 111,626 $ 123,157 |
Assets Held-For-Sale Divestit_2
Assets Held-For-Sale Divestiture (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Asset Retirement Obligation Disclosure [Abstract] | |
Schedule of Components Held-for Sale | The components of held-for-sale assets and liabilities at September 30, 2023 were as follows (in thousands): Assets held-for-sale Accounts receivable, net of allowance for credit losses $ 5,491 Inventories, net 7,092 Other current assets 2,131 Intangibles, net 7,069 Goodwill 10,668 Other assets 1,267 Total assets held-for-sale $ 33,718 Liabilities held-for-sale Current liabilities $ 6,045 Other liabilities 2,476 Total liabilities held-for-sale $ 8,521 |
Goodwill and Intangible Assets
Goodwill and Intangible Assets (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Goodwill by Reportable Segments | Goodwill by reportable segment was as follows (in thousands): Probe Cards Systems Total Goodwill, as of December 25, 2021 $ 178,424 $ 33,875 $ 212,299 Addition - Woburn Acquisition — 550 550 Foreign currency translation — (1,405) (1,405) Goodwill, as of December 31, 2022 178,424 33,020 211,444 Reclassification - Assets held-for-sale — (10,668) (10,668) Foreign currency translation — (291) (291) Goodwill, as of September 30, 2023 $ 178,424 $ 22,061 $ 200,485 |
Schedule of Intangible Assets | Intangible assets were as follows (in thousands): September 30, 2023 December 31, 2022 Intangible Assets Gross Accumulated Net Gross Accumulated Net Existing developed technologies $ 159,115 $ 147,517 $ 11,598 $ 171,441 $ 151,212 $ 20,229 Customer relationships 47,877 46,388 1,489 50,912 45,003 5,909 Trade name 7,754 7,663 91 7,972 7,759 213 In-process research and development 400 — 400 400 — 400 $ 215,146 $ 201,568 $ 13,578 $ 230,725 $ 203,974 $ 26,751 |
Schedule of Amortization Expense | Amortization expense was included in our Condensed Consolidated Statements of Income as follows (in thousands): Three Months Ended Nine Months Ended September 30, September 24, September 30, September 24, Cost of revenues $ 837 $ 824 $ 2,506 $ 2,420 Selling, general and administrative 440 1,530 3,537 4,636 $ 1,277 $ 2,354 $ 6,043 $ 7,056 |
Schedule of Estimated Amortization of Intangible Assets | The estimated future amortization of definite-lived intangible assets, excluding in-process research and development, is as follows (in thousands): Fiscal Year Amount Remainder of 2023 $ 640 2024 2,561 2025 2,330 2026 1,630 2027 1,630 Thereafter 4,387 $ 13,178 |
Accrued Liabilities (Tables)
Accrued Liabilities (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Payables and Accruals [Abstract] | |
Schedule of Accrued Liabilities | Accrued liabilities consisted of the following (in thousands): September 30, December 31, Accrued compensation and benefits $ 22,684 $ 15,864 Accrued warranty 4,984 4,199 Employee stock purchase plan contributions withheld 1,576 4,585 Accrued income and other taxes 2,761 12,817 Accrued restructuring charges 29 1,249 Other accrued expenses 4,453 3,401 $ 36,487 $ 42,115 |
Restructuring Charges (Tables)
Restructuring Charges (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Restructuring and Related Activities [Abstract] | |
Restructuring Costs by Reportable Segment | Total restructuring charges for both the 2022 and 2021 restructuring plans included in our Condensed Consolidated Statements of Income were as follows (in thousands): Three Months Ended September 30, 2023 September 24, 2022 Probe Cards Systems Total Probe Cards Systems Total Cost of revenues $ — $ — $ — $ 5,928 $ 132 $ 6,060 Research and development — — — 38 29 67 Selling, general and administrative — — — — 47 47 $ — $ — $ — $ 5,966 $ 208 $ 6,174 Nine Months Ended September 30, 2023 September 24, 2022 Probe Cards Systems Total Probe Cards Systems Total Cost of revenues $ 106 $ 251 $ 357 $ 6,194 $ 459 $ 6,653 Research and development 182 109 291 38 228 266 Selling, general and administrative 1,069 118 1,187 3 146 149 $ 1,357 $ 478 $ 1,835 $ 6,235 $ 833 $ 7,068 |
Schedule of Restructuring Accrual Activity | Changes to the restructuring accrual in the nine months ended September 30, 2023 were as follows (in thousands): Employee Severance Stock-based Compensation Inventory Contract Total December 31, 2022 $ 1,249 $ — $ — $ — $ 1,249 Restructuring charges 917 295 390 233 1,835 Cash payments (2,137) — (89) (233) (2,459) Non-cash settlement — (295) (301) — (596) September 30, 2023 $ 29 $ — $ — $ — $ 29 |
Fair Value and Derivative Ins_2
Fair Value and Derivative Instruments (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of Fair Value Assets Measured on Recurring Basis | Assets and liabilities measured at fair value on a recurring basis were as follows (in thousands): September 30, 2023 Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 26,936 $ — $ — $ 26,936 U.S. treasuries 2,290 — — 2,290 Commercial paper — 1,790 — 1,790 29,226 1,790 — 31,016 Marketable securities: U.S. treasuries 46,403 — — 46,403 Certificates of deposit — 238 — 238 U.S. agency securities — 12,141 — 12,141 Corporate bonds — 61,106 — 61,106 Commercial paper — 15,805 — 15,805 46,403 89,290 — 135,693 Promissory note receivable — — 922 922 Interest rate swap derivative contract — 2,536 — 2,536 Total assets $ 75,629 $ 93,616 $ 922 $ 170,167 Liabilities: Foreign exchange derivative contracts $ — $ (781) $ — $ (781) Total liabilities $ — $ (781) $ — $ (781) December 31, 2022 Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 21,279 $ — $ — $ 21,279 Commercial paper — 4,969 — 4,969 U.S. agency securities — 996 — 996 21,279 5,965 — 27,244 Marketable securities: U.S. treasuries 25,019 — — 25,019 Certificates of deposit — 706 — 706 U.S. agency securities — 11,045 — 11,045 Corporate bonds — 67,396 — 67,396 Commercial paper — 24,840 — 24,840 25,019 103,987 — 129,006 Foreign exchange derivative contracts — 664 — 664 Promissory note receivable — — 943 943 Interest rate swap derivative contract — 2,374 — 2,374 Total assets $ 46,298 $ 112,990 $ 943 $ 160,231 Liabilities: Foreign exchange derivative contracts $ — $ (193) $ — $ (193) Total liabilities $ — $ (193) $ — $ (193) |
Schedule of Foreign Currency Forward Contracts | The following table provides information about our foreign currency forward contracts outstanding as of September 30, 2023 (in thousands): Currency Contract Position Contract Amount Contract Amount Euro Dollar Buy 20,312 $ 22,427 Euro Dollar Sell 3,576 3,786 Japanese Yen Sell 2,759,293 18,535 Korean Won Buy 1,520,865 1,133 Taiwan Dollar Sell 59,367 1,839 |
Warranty (Tables)
Warranty (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Product Warranties Disclosures [Abstract] | |
Schedule of Reconciliation of Changes in Warranty Liability | Changes in our warranty liability were as follows (in thousands): Nine Months Ended September 30, September 24, Balance at beginning of period $ 4,199 $ 2,805 Accruals 6,426 5,653 Settlements (5,535) (4,652) Reclassification - Liabilities held-for-sale (106) — Balance at end of period $ 4,984 $ 3,806 |
Property, Plant, and Equipmen_2
Property, Plant, and Equipment, net (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property, Plant and Equipment | Property, plant and equipment, net consisted of the following (in thousands): September 30, December 31, Land $ 17,136 $ 17,136 Building and building improvements 44,452 44,932 Machinery and equipment 286,033 276,180 Computer equipment and software 46,968 45,813 Furniture and fixtures 7,471 7,540 Leasehold improvements 90,813 86,500 Sub-total 492,873 478,101 Less: Accumulated depreciation and amortization (353,796) (335,711) Net, property, plant and equipment 139,077 142,390 Construction-in-process 64,433 47,458 Total $ 203,510 $ 189,848 |
Stockholders_ Equity and Stoc_2
Stockholders’ Equity and Stock-Based Compensation (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Equity [Abstract] | |
Schedule of Restricted Stock Unit Activity | Restricted stock unit (“RSU”) activity under our equity incentive plan was as follows: Units Weighted Average Grant Date Fair Value RSUs at December 31, 2022 2,227,081 $ 35.28 Awards granted 1,402,715 33.84 Awards vested (830,549) 33.56 Awards forfeited (336,753) 30.14 RSUs at September 30, 2023 2,462,494 35.74 |
Schedule of ESPP Activity | Information related to activity under our Employee Stock Purchase Plan (“ESPP”) was as follows: Nine Months Ended September 30, 2023 Shares issued 363,190 Weighted average per share purchase price $ 24.29 Weighted average per share discount from the fair value of our common stock on the date of issuance $ 7.65 |
Schedule of Stock-based Compensation | Stock-based compensation was included in our Condensed Consolidated Statements of Income as follows (in thousands): Three Months Ended Nine Months Ended September 30, September 24, September 30, September 24, Cost of revenues $ 1,376 $ 1,022 $ 4,801 $ 2,834 Research and development 3,173 2,027 7,908 5,708 Selling, general and administrative 6,290 4,946 16,624 13,331 Total stock-based compensation $ 10,839 $ 7,995 $ 29,333 $ 21,873 |
Schedule of Unrecognized Stock-based Compensation | At September 30, 2023, the unrecognized stock-based compensation was as follows (dollars in thousands): Unrecognized Expense Average Expected Restricted stock units $ 58,985 2.21 Performance restricted stock units 14,667 2.20 Employee stock purchase plan 1,498 0.25 Total unrecognized stock-based compensation expense $ 75,150 2.17 |
Net Income per Share (Tables)
Net Income per Share (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Earnings Per Share [Abstract] | |
Schedule of Calculation of Numerator and Denominator in Earnings Per Share | The following table reconciles the shares used in calculating basic net income per share and diluted net income per share (in thousands): Three Months Ended Nine Months Ended September 30, September 24, September 30, September 24, Weighted-average shares used in computing basic net income per share 77,571 77,245 77,265 77,796 Add potentially dilutive securities 841 443 595 696 Weighted-average shares used in computing diluted net income per share 78,412 77,688 77,860 78,492 Securities not included as they would have been antidilutive 172 897 94 266 |
Leases (Tables)
Leases (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Leases [Abstract] | |
Schedule of Components of Lease Expense | The components of lease expense were as follows (in thousands): Three Months Ended Nine Months Ended September 30, September 24, September 30, September 24, Lease expense: Operating lease expense $ 2,157 $ 2,118 $ 6,233 $ 6,522 Short-term lease expense 126 135 419 251 Variable lease expense 625 590 1,854 1,725 $ 2,908 $ 2,843 $ 8,506 $ 8,498 |
Schedule of Future Minimum Payments Under Leases | Future minimum payments under our non-cancelable operating leases were as follows as of September 30, 2023 (in thousands): Fiscal Year Amount Remainder of 2023 $ 2,175 2024 8,773 2025 8,670 2026 7,151 2027 6,734 Thereafter 3,541 Total minimum lease payments 37,044 Less: interest (3,941) Present value of net minimum lease payments 33,103 Less: current portion (8,007) Total long-term operating lease liabilities $ 25,096 |
Operating Segments and Enterp_2
Operating Segments and Enterprise-Wide Information (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Segment Reporting [Abstract] | |
Schedule of Operating Results by Segment | The following table summarizes the operating results by reportable segment (dollars in thousands): Three Months Ended September 30, 2023 September 24, 2022 Probe Cards Systems Corporate and Other Total Probe Cards Systems Corporate and Other Total Revenues $ 128,339 $ 43,236 $ — $ 171,575 $ 139,365 $ 41,504 $ — $ 180,869 Gross profit 49,383 22,396 (2,494) 69,285 48,252 22,284 (8,323) 62,213 Gross margin 38.5 % 51.8 % 40.4 % 34.6 % 53.7 % 34.4 % Nine Months Ended September 30, 2023 September 24, 2022 Probe Cards Systems Corporate and Other Total Probe Cards Systems Corporate and Other Total Revenues $ 370,970 $ 123,969 $ — $ 494,939 $ 467,056 $ 114,894 $ — $ 581,950 Gross profit 135,118 64,266 (8,738) 190,646 203,874 59,967 (13,035) 250,806 Gross margin 36.4 % 51.8 % 38.5 % 43.7 % 52.2 % 43.1 % |
Schedule of Disaggregation of Revenue by Segment | Certain revenue category information by reportable segment was as follows (in thousands): Three Months Ended September 30, 2023 September 24, 2022 Probe Cards Systems Total Probe Cards Systems Total Market: Foundry & Logic $ 96,366 $ — $ 96,366 $ 90,605 $ — $ 90,605 DRAM 27,478 — 27,478 34,922 — 34,922 Flash 4,495 — 4,495 13,838 — 13,838 Systems — 43,236 43,236 — 41,504 41,504 Total $ 128,339 $ 43,236 $ 171,575 $ 139,365 $ 41,504 $ 180,869 Timing of revenue recognition: Products transferred at a point in time $ 127,731 $ 41,776 $ 169,507 $ 138,602 $ 37,842 $ 176,444 Products and services transferred over time 608 1,460 2,068 763 3,662 4,425 Total $ 128,339 $ 43,236 $ 171,575 $ 139,365 $ 41,504 $ 180,869 Geographical region: United States $ 31,182 $ 12,543 $ 43,725 $ 25,909 $ 12,180 $ 38,089 Taiwan 39,155 3,820 42,975 32,227 4,611 36,838 South Korea 31,805 3,270 35,075 28,118 819 28,937 China 10,779 10,971 21,750 27,973 8,755 36,728 Europe 2,583 6,713 9,296 3,682 8,116 11,798 Japan 2,976 3,988 6,964 4,533 3,159 7,692 Malaysia 5,778 186 5,964 6,272 237 6,509 Singapore 2,752 925 3,677 7,983 2,374 10,357 Rest of the world 1,329 820 2,149 2,668 1,253 3,921 Total $ 128,339 $ 43,236 $ 171,575 $ 139,365 $ 41,504 $ 180,869 Nine Months Ended September 30, 2023 September 24, 2022 Probe Cards Systems Total Probe Cards Systems Total Market: Foundry & Logic $ 279,895 $ — $ 279,895 $ 327,106 $ — $ 327,106 DRAM 77,832 — 77,832 106,202 — 106,202 Flash 13,243 — 13,243 33,748 — 33,748 Systems — 123,969 123,969 — 114,894 114,894 Total $ 370,970 $ 123,969 $ 494,939 $ 467,056 $ 114,894 $ 581,950 Timing of revenue recognition: Products transferred at a point in time $ 368,939 $ 116,981 $ 485,920 $ 464,139 $ 106,339 $ 570,478 Products and services transferred over time 2,031 6,988 9,019 2,917 8,555 11,472 Total $ 370,970 $ 123,969 $ 494,939 $ 467,056 $ 114,894 $ 581,950 Geographical region: United States $ 86,954 $ 37,175 $ 124,129 $ 67,424 $ 27,554 $ 94,978 Taiwan 103,368 9,448 112,816 119,937 19,990 139,927 South Korea 77,832 5,881 83,713 80,417 4,776 85,193 China 45,771 26,586 72,357 101,342 23,520 124,862 Europe 8,424 21,114 29,538 9,888 18,396 28,284 Japan 14,014 11,859 25,873 16,034 10,977 27,011 Malaysia 22,279 1,632 23,911 43,946 1,006 44,952 Singapore 7,670 4,170 11,840 23,398 4,963 28,361 Rest of the world 4,658 6,104 10,762 4,670 3,712 8,382 Total $ 370,970 $ 123,969 $ 494,939 $ 467,056 $ 114,894 $ 581,950 |
Basis of Presentation and Sig_3
Basis of Presentation and Significant Accounting Policies (Details) - USD ($) $ in Thousands | 1 Months Ended | ||
Jan. 31, 2023 | Sep. 30, 2023 | Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||
Cash received from grant | $ 18,000 | $ 18,000 | $ 0 |
Grant term | 5 years |
Concentration of Credit and O_3
Concentration of Credit and Other Risks (Details) - Customer Concentration Risk | 3 Months Ended | 6 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Jul. 01, 2023 | Sep. 30, 2023 | Sep. 24, 2022 | |
Revenue Benchmark | Two Major Customers | |||||
Concentration Risk [Line Items] | |||||
Concentration risk percentage | 10% | 10% | |||
Revenue from Contract with Customer Benchmark | Intel Corporation | |||||
Concentration Risk [Line Items] | |||||
Concentration risk percentage | 17.10% | 17% | 17.20% | 19.70% | |
Revenue from Contract with Customer Benchmark | Samsung Electronics., LTD. | |||||
Concentration Risk [Line Items] | |||||
Concentration risk percentage | 11.20% | ||||
Revenue from Contract with Customer Benchmark | SK Hynix Inc. | |||||
Concentration Risk [Line Items] | |||||
Concentration risk percentage | 10.70% | ||||
Revenue from Contract with Customer Benchmark | Customers Representing 10% or More of Total Revenues | |||||
Concentration Risk [Line Items] | |||||
Concentration risk percentage | 28.30% | 27.70% | 17.20% | 19.70% | |
Accounts Receivable | Major Customer 1 | |||||
Concentration Risk [Line Items] | |||||
Concentration risk percentage | 13.80% | 23.50% |
Inventories, net (Details)
Inventories, net (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Inventory Disclosure [Abstract] | ||
Raw materials | $ 50,641 | $ 55,726 |
Work-in-progress | 40,150 | 46,067 |
Finished goods | 20,835 | 21,364 |
Inventories | $ 111,626 | $ 123,157 |
Assets Held-For-Sale Divestit_3
Assets Held-For-Sale Divestiture (Details) - Disposal Group, Held-for-Sale, Not Discontinued Operations - FRT Metrology - USD ($) $ in Millions | Nov. 01, 2023 | Sep. 18, 2023 | Dec. 31, 2019 |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||
Cash consideration | $ 100 | $ 24.4 | |
Subsequent Event | |||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||
Cash received, adjusted amount | $ 103.8 |
Assets Held-For-Sale Divestit_4
Assets Held-For-Sale Divestiture - Schedule of Assets and Liabilities Held-for-Sale (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Assets held-for-sale | ||
Total assets held-for-sale | $ 33,718 | $ 0 |
Liabilities held-for-sale | ||
Total liabilities held-for-sale | 8,521 | $ 0 |
Disposal Group, Held-for-Sale, Not Discontinued Operations | FRT Metrology | ||
Assets held-for-sale | ||
Accounts receivable, net of allowance for credit losses | 5,491 | |
Inventories, net | 7,092 | |
Other current assets | 2,131 | |
Intangibles, net | 7,069 | |
Goodwill | 10,668 | |
Other assets | 1,267 | |
Total assets held-for-sale | 33,718 | |
Liabilities held-for-sale | ||
Current liabilities | 6,045 | |
Other liabilities | 2,476 | |
Total liabilities held-for-sale | $ 8,521 |
Goodwill and Intangible Asset_2
Goodwill and Intangible Assets - Goodwill (Details) - USD ($) $ in Thousands | 9 Months Ended | 12 Months Ended |
Sep. 30, 2023 | Dec. 31, 2022 | |
Goodwill [Roll Forward] | ||
Goodwill, beginning balance | $ 211,444 | $ 212,299 |
Reclassification - Assets held-for-sale | (10,668) | |
Foreign currency translation | (291) | (1,405) |
Goodwill, ending balance | 200,485 | 211,444 |
Woburn | ||
Goodwill [Roll Forward] | ||
Goodwill, acquired during period | 550 | |
Probe Cards | ||
Goodwill [Roll Forward] | ||
Goodwill, beginning balance | 178,424 | 178,424 |
Reclassification - Assets held-for-sale | 0 | |
Foreign currency translation | 0 | 0 |
Goodwill, ending balance | 178,424 | 178,424 |
Probe Cards | Woburn | ||
Goodwill [Roll Forward] | ||
Goodwill, acquired during period | 0 | |
Systems | ||
Goodwill [Roll Forward] | ||
Goodwill, beginning balance | 33,020 | 33,875 |
Reclassification - Assets held-for-sale | (10,668) | |
Foreign currency translation | (291) | (1,405) |
Goodwill, ending balance | $ 22,061 | 33,020 |
Systems | Woburn | ||
Goodwill [Roll Forward] | ||
Goodwill, acquired during period | $ 550 |
Goodwill and Intangible Asset_3
Goodwill and Intangible Assets - Additional information (Details) | 9 Months Ended |
Sep. 30, 2023 USD ($) | |
Goodwill [Line Items] | |
Goodwill, impairment loss | $ 0 |
Disposal Group, Held-for-Sale, Not Discontinued Operations | FRT Metrology | |
Goodwill [Line Items] | |
Intangibles, net | $ 7,100,000 |
Goodwill and Intangible Asset_4
Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Finite-Lived Intangible Assets [Line Items] | ||
Gross | $ 215,146 | $ 230,725 |
Accumulated Amortization | 201,568 | 203,974 |
Net | 13,578 | 26,751 |
Existing developed technologies | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross | 159,115 | 171,441 |
Accumulated Amortization | 147,517 | 151,212 |
Net | 11,598 | 20,229 |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross | 47,877 | 50,912 |
Accumulated Amortization | 46,388 | 45,003 |
Net | 1,489 | 5,909 |
Trade name | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross | 7,754 | 7,972 |
Accumulated Amortization | 7,663 | 7,759 |
Net | 91 | 213 |
In-process research and development | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross | 400 | 400 |
Accumulated Amortization | 0 | 0 |
Net | $ 400 | $ 400 |
Goodwill and Intangible Asset_5
Goodwill and Intangible Assets - Amortization Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
Property, Plant and Equipment [Line Items] | ||||
Amortization of intangible assets | $ 1,277 | $ 2,354 | $ 6,043 | $ 7,056 |
Finite-Lived Intangible Assets, Net, Amortization Expense, Rolling Maturity [Abstract] | ||||
Remainder of 2023 | 640 | 640 | ||
2024 | 2,561 | 2,561 | ||
2025 | 2,330 | 2,330 | ||
2026 | 1,630 | 1,630 | ||
2027 | 1,630 | 1,630 | ||
Thereafter | 4,387 | 4,387 | ||
Net | 13,178 | 13,178 | ||
Cost of revenues | ||||
Property, Plant and Equipment [Line Items] | ||||
Amortization of intangible assets | 837 | 824 | 2,506 | 2,420 |
Selling, general and administrative | ||||
Property, Plant and Equipment [Line Items] | ||||
Amortization of intangible assets | $ 440 | $ 1,530 | $ 3,537 | $ 4,636 |
Accrued Liabilities (Details)
Accrued Liabilities (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Payables and Accruals [Abstract] | ||
Accrued compensation and benefits | $ 22,684 | $ 15,864 |
Accrued income and other taxes | 2,761 | 12,817 |
Accrued warranty | 4,984 | 4,199 |
Employee stock purchase plan contributions withheld | 1,576 | 4,585 |
Accrued restructuring charges | 29 | 1,249 |
Other accrued expenses | 4,453 | 3,401 |
Accrued liabilities | $ 36,487 | $ 42,115 |
Debt (Details)
Debt (Details) - Building Term Loan - USD ($) $ in Millions | Jun. 22, 2020 | Mar. 17, 2020 | Sep. 30, 2023 |
Debt Instrument [Line Items] | |||
Interest rate at period end | 7.19% | ||
Maximum borrowing capacity | $ 18 | ||
Long-term debt, term | 15 years | ||
Interest payment term | 15 years | ||
Interest rate, effective percentage | 2.75% | ||
Interest Rate Contract | |||
Debt Instrument [Line Items] | |||
Derivative, notional amount | $ 18 | ||
SOFR | |||
Debt Instrument [Line Items] | |||
Basis spread on variable rate | 1.75% | ||
Additional SOFR | |||
Debt Instrument [Line Items] | |||
Basis spread on variable rate | 0.1148% | ||
LIBOR | |||
Debt Instrument [Line Items] | |||
Basis spread on variable rate | 1.75% |
Restructuring Charges - Narrati
Restructuring Charges - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | 5 Months Ended | 9 Months Ended | 18 Months Ended | |||
Oct. 25, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | Apr. 01, 2023 | Sep. 30, 2023 | Sep. 24, 2022 | Apr. 01, 2023 | |
Restructuring Cost and Reserve [Line Items] | |||||||
Restructuring charges | $ 0 | $ 6,174 | $ 1,835 | $ 7,068 | |||
Stock-based Compensation | |||||||
Restructuring Cost and Reserve [Line Items] | |||||||
Restructuring charges | 295 | ||||||
Employee Severance and Benefits | |||||||
Restructuring Cost and Reserve [Line Items] | |||||||
Restructuring charges | 917 | ||||||
Contract Termination & Other Costs | |||||||
Restructuring Cost and Reserve [Line Items] | |||||||
Restructuring charges | 233 | ||||||
Inventory Impairments & Other Inventory Related Costs | |||||||
Restructuring Cost and Reserve [Line Items] | |||||||
Restructuring charges | 390 | ||||||
Probe Cards | |||||||
Restructuring Cost and Reserve [Line Items] | |||||||
Restructuring charges | 0 | 5,966 | 1,357 | 6,235 | |||
Systems | |||||||
Restructuring Cost and Reserve [Line Items] | |||||||
Restructuring charges | $ 0 | $ 208 | $ 478 | $ 833 | |||
2022 Restructuring Plan | |||||||
Restructuring Cost and Reserve [Line Items] | |||||||
Percent of workforce eliminated | 13% | ||||||
Restructuring charges | $ 8,100 | ||||||
2022 Restructuring Plan | Stock-based Compensation | |||||||
Restructuring Cost and Reserve [Line Items] | |||||||
Restructuring charges | 300 | ||||||
2022 Restructuring Plan | Corporate, Non-Segment | |||||||
Restructuring Cost and Reserve [Line Items] | |||||||
Restructuring charges | 500 | ||||||
2022 Restructuring Plan | Probe Cards | |||||||
Restructuring Cost and Reserve [Line Items] | |||||||
Restructuring charges | 7,100 | ||||||
2022 Restructuring Plan | Systems | |||||||
Restructuring Cost and Reserve [Line Items] | |||||||
Restructuring charges | $ 500 | ||||||
2021 Restructuring Plan | |||||||
Restructuring Cost and Reserve [Line Items] | |||||||
Restructuring charges | $ 13,300 | ||||||
2021 Restructuring Plan | Employee Severance and Benefits | |||||||
Restructuring Cost and Reserve [Line Items] | |||||||
Restructuring charges | 1,400 | ||||||
2021 Restructuring Plan | Contract Termination & Other Costs | |||||||
Restructuring Cost and Reserve [Line Items] | |||||||
Restructuring charges | 2,000 | ||||||
2021 Restructuring Plan | Inventory Impairments & Other Inventory Related Costs | |||||||
Restructuring Cost and Reserve [Line Items] | |||||||
Restructuring charges | 9,400 | ||||||
2021 Restructuring Plan | Other Costs | |||||||
Restructuring Cost and Reserve [Line Items] | |||||||
Restructuring charges | 500 | ||||||
2021 Restructuring Plan | Probe Cards | |||||||
Restructuring Cost and Reserve [Line Items] | |||||||
Restructuring charges | 10,100 | ||||||
2021 Restructuring Plan | Systems | |||||||
Restructuring Cost and Reserve [Line Items] | |||||||
Restructuring charges | $ 3,200 |
Restructuring Charges - Restruc
Restructuring Charges - Restructuring Charges (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | Dec. 31, 2022 | |
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring charges | $ 0 | $ 6,174 | $ 1,835 | $ 7,068 | |
Accrued restructuring charges | 29 | 29 | $ 1,249 | ||
Cash payments | (2,459) | ||||
Non-cash settlement | (596) | ||||
Cost of revenues | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring charges | 0 | 6,060 | 357 | 6,653 | |
Research and development | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring charges | 0 | 67 | 291 | 266 | |
Selling, general and administrative | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring charges | 0 | 47 | 1,187 | 149 | |
Probe Cards | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring charges | 0 | 5,966 | 1,357 | 6,235 | |
Probe Cards | Cost of revenues | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring charges | 0 | 5,928 | 106 | 6,194 | |
Probe Cards | Research and development | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring charges | 0 | 38 | 182 | 38 | |
Probe Cards | Selling, general and administrative | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring charges | 0 | 0 | 1,069 | 3 | |
Systems | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring charges | 0 | 208 | 478 | 833 | |
Systems | Cost of revenues | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring charges | 0 | 132 | 251 | 459 | |
Systems | Research and development | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring charges | 0 | 29 | 109 | 228 | |
Systems | Selling, general and administrative | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring charges | $ 0 | $ 47 | $ 118 | $ 146 |
Restructuring Charges - Changes
Restructuring Charges - Changes to the Restructuring Accrual (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
Restructuring Reserve [Roll Forward] | ||||
Accrual at beginning of period | $ 1,249 | |||
Restructuring charges | $ 0 | $ 6,174 | 1,835 | $ 7,068 |
Cash payments | (2,459) | |||
Non-cash settlement | (596) | |||
Accrual at end of period | 29 | 29 | ||
Employee Severance and Benefits | ||||
Restructuring Reserve [Roll Forward] | ||||
Accrual at beginning of period | 1,249 | |||
Restructuring charges | 917 | |||
Cash payments | (2,137) | |||
Non-cash settlement | 0 | |||
Accrual at end of period | 29 | 29 | ||
Stock-based Compensation | ||||
Restructuring Reserve [Roll Forward] | ||||
Accrual at beginning of period | 0 | |||
Restructuring charges | 295 | |||
Cash payments | 0 | |||
Non-cash settlement | (295) | |||
Accrual at end of period | 0 | 0 | ||
Inventory Impairments & Other Inventory Related Costs | ||||
Restructuring Reserve [Roll Forward] | ||||
Accrual at beginning of period | 0 | |||
Restructuring charges | 390 | |||
Cash payments | (89) | |||
Non-cash settlement | (301) | |||
Accrual at end of period | 0 | 0 | ||
Contract Termination & Other Costs | ||||
Restructuring Reserve [Roll Forward] | ||||
Accrual at beginning of period | 0 | |||
Restructuring charges | 233 | |||
Cash payments | (233) | |||
Non-cash settlement | 0 | |||
Accrual at end of period | $ 0 | $ 0 |
Fair Value and Derivative Ins_3
Fair Value and Derivative Instruments - Fair Value Assets Measured on Recurring Basis (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | $ 31,016 | $ 27,244 |
Marketable securities | 135,693 | 129,006 |
Total assets | 170,167 | 160,231 |
Total liabilities | (781) | (193) |
Foreign exchange derivative contracts | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative liability | (781) | |
Foreign exchange derivative contracts | Designated as hedging instrument | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative contracts | 664 | |
Derivative liability | (193) | |
Promissory note receivable | Designated as hedging instrument | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative contracts | 922 | 943 |
Interest rate swap derivative contract | Designated as hedging instrument | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative contracts | 2,536 | 2,374 |
Money market funds | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 26,936 | 21,279 |
Commercial paper | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 1,790 | 4,969 |
Marketable securities | 15,805 | |
Commercial paper | Designated as hedging instrument | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Marketable securities | 24,840 | |
Corporate bonds | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Marketable securities | 61,106 | 67,396 |
U.S. treasuries | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 2,290 | |
Marketable securities | 46,403 | 25,019 |
Certificates of deposit | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Marketable securities | 238 | 706 |
U.S. agency securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 996 | |
Marketable securities | 12,141 | 11,045 |
Level 1 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 29,226 | 21,279 |
Marketable securities | 46,403 | 25,019 |
Total assets | 75,629 | 46,298 |
Total liabilities | 0 | 0 |
Level 1 | Foreign exchange derivative contracts | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative liability | 0 | |
Level 1 | Foreign exchange derivative contracts | Designated as hedging instrument | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative contracts | 0 | |
Derivative liability | 0 | |
Level 1 | Promissory note receivable | Designated as hedging instrument | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative contracts | 0 | 0 |
Level 1 | Interest rate swap derivative contract | Designated as hedging instrument | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative contracts | 0 | 0 |
Level 1 | Money market funds | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 26,936 | 21,279 |
Level 1 | Commercial paper | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 0 | 0 |
Marketable securities | 0 | |
Level 1 | Commercial paper | Designated as hedging instrument | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Marketable securities | 0 | |
Level 1 | Corporate bonds | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Marketable securities | 0 | 0 |
Level 1 | U.S. treasuries | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 2,290 | |
Marketable securities | 46,403 | 25,019 |
Level 1 | Certificates of deposit | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Marketable securities | 0 | 0 |
Level 1 | U.S. agency securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 0 | |
Marketable securities | 0 | 0 |
Level 2 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 1,790 | 5,965 |
Marketable securities | 89,290 | 103,987 |
Total assets | 93,616 | 112,990 |
Total liabilities | (781) | (193) |
Level 2 | Foreign exchange derivative contracts | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative liability | (781) | |
Level 2 | Foreign exchange derivative contracts | Designated as hedging instrument | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative contracts | 664 | |
Derivative liability | (193) | |
Level 2 | Promissory note receivable | Designated as hedging instrument | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative contracts | 0 | 0 |
Level 2 | Interest rate swap derivative contract | Designated as hedging instrument | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative contracts | 2,536 | 2,374 |
Level 2 | Money market funds | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 0 | 0 |
Level 2 | Commercial paper | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 1,790 | 4,969 |
Marketable securities | 15,805 | |
Level 2 | Commercial paper | Designated as hedging instrument | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Marketable securities | 24,840 | |
Level 2 | Corporate bonds | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Marketable securities | 61,106 | 67,396 |
Level 2 | U.S. treasuries | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 0 | |
Marketable securities | 0 | 0 |
Level 2 | Certificates of deposit | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Marketable securities | 238 | 706 |
Level 2 | U.S. agency securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 996 | |
Marketable securities | 12,141 | 11,045 |
Level 3 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 0 | 0 |
Marketable securities | 0 | 0 |
Total assets | 922 | 943 |
Total liabilities | 0 | 0 |
Level 3 | Foreign exchange derivative contracts | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative liability | 0 | |
Level 3 | Foreign exchange derivative contracts | Designated as hedging instrument | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative contracts | 0 | |
Derivative liability | 0 | |
Level 3 | Promissory note receivable | Designated as hedging instrument | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative contracts | 922 | 943 |
Level 3 | Interest rate swap derivative contract | Designated as hedging instrument | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Derivative contracts | 0 | 0 |
Level 3 | Money market funds | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 0 | 0 |
Level 3 | Commercial paper | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 0 | 0 |
Marketable securities | 0 | |
Level 3 | Commercial paper | Designated as hedging instrument | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Marketable securities | 0 | |
Level 3 | Corporate bonds | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Marketable securities | 0 | 0 |
Level 3 | U.S. treasuries | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 0 | |
Marketable securities | 0 | 0 |
Level 3 | Certificates of deposit | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Marketable securities | 0 | 0 |
Level 3 | U.S. agency securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Cash equivalents | 0 | |
Marketable securities | $ 0 | $ 0 |
Fair Value and Derivative Ins_4
Fair Value and Derivative Instruments - Foreign Currency Forward Contracts (Details) - Sep. 30, 2023 - Foreign Exchange Forward € in Thousands, ₩ in Thousands, ¥ in Thousands, $ in Thousands, $ in Thousands | USD ($) | EUR (€) | JPY (¥) | KRW (₩) | TWD ($) |
Buy | Euro Dollar | |||||
Derivative [Line Items] | |||||
Derivative, notional amount | $ 22,427 | € 20,312 | |||
Buy | Korean Won | |||||
Derivative [Line Items] | |||||
Derivative, notional amount | 1,133 | ₩ 1,520,865 | |||
Sell | Euro Dollar | |||||
Derivative [Line Items] | |||||
Derivative, notional amount | 3,786 | € 3,576 | |||
Sell | Japanese Yen | |||||
Derivative [Line Items] | |||||
Derivative, notional amount | 18,535 | ¥ 2,759,293 | |||
Sell | Taiwan Dollar | |||||
Derivative [Line Items] | |||||
Derivative, notional amount | $ 1,839 | $ 59,367 |
Fair Value and Derivative Ins_5
Fair Value and Derivative Instruments - Additional Information (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 | Sep. 24, 2022 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets measured at fair value on non-recurring basis | $ 170,167,000 | $ 160,231,000 | |
Liabilities measured at fair value on non-recurring basis | 781,000 | $ 193,000 | |
Nonrecurring | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets measured at fair value on non-recurring basis | 0 | $ 0 | |
Liabilities measured at fair value on non-recurring basis | $ 0 | $ 0 |
Warranty (Details)
Warranty (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2023 | Sep. 24, 2022 | |
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward] | ||
Balance at beginning of period | $ 4,199 | $ 2,805 |
Accruals | 6,426 | 5,653 |
Settlements | (5,535) | (4,652) |
Reclassification - Liabilities held-for-sale | (106) | 0 |
Balance at end of period | $ 4,984 | $ 3,806 |
Property, Plant, and Equipmen_3
Property, Plant, and Equipment, net (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Sep. 30, 2023 | Dec. 31, 2022 | |
Property, Plant and Equipment [Line Items] | ||
Sub-total | $ 492,873 | $ 478,101 |
Less: Accumulated depreciation and amortization | (353,796) | (335,711) |
Net, property, plant and equipment | 139,077 | 142,390 |
Construction-in-process | 64,433 | 47,458 |
Total | 203,510 | 189,848 |
Reclassification | 900 | |
Land | ||
Property, Plant and Equipment [Line Items] | ||
Sub-total | 17,136 | 17,136 |
Building and building improvements | ||
Property, Plant and Equipment [Line Items] | ||
Sub-total | 44,452 | 44,932 |
Machinery and equipment | ||
Property, Plant and Equipment [Line Items] | ||
Sub-total | 286,033 | 276,180 |
Computer equipment and software | ||
Property, Plant and Equipment [Line Items] | ||
Sub-total | 46,968 | 45,813 |
Furniture and fixtures | ||
Property, Plant and Equipment [Line Items] | ||
Sub-total | 7,471 | 7,540 |
Leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Sub-total | $ 90,813 | $ 86,500 |
Stockholders_ Equity and Stoc_3
Stockholders’ Equity and Stock-Based Compensation - Additional Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||
Oct. 30, 2023 | Aug. 07, 2023 | Oct. 26, 2020 | Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | Dec. 26, 2020 | May 20, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Purchase of common stock value retired through repurchase program | $ 19,150,000 | $ 73,478,000 | |||||||
PRSUs | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Awards granted (in shares) | 172,680 | ||||||||
Fair value of awards granted | $ 8,600,000 | ||||||||
Vested (in shares) | 0 | ||||||||
Outstanding (in shares) | 191,400 | 191,400 | |||||||
PRSUs | 2020 PSU Grant | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Awards granted (in shares) | 258,600 | ||||||||
October2023 Stock Repurchase Program | Subsequent Event | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Stock repurchase program duration | 2 years | ||||||||
Common Stock | October 2020 Stock Repurchase Program | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Stock repurchase program authorized amount | $ 50,000,000 | ||||||||
Stock repurchase program duration | 2 years | ||||||||
Common Stock | May 2022 Stock Repurchase Program | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Stock repurchase program authorized amount | $ 75,000,000 | ||||||||
Purchase of common stock retired through repurchase program (in shares) | 0 | ||||||||
Amount remaining for future repurchases | $ 18,600,000 | $ 18,600,000 | |||||||
Common Stock | 2020 Share Repurchase Program | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Purchase of common stock retired through repurchase program (in shares) | 676,408 | ||||||||
Purchase of common stock value retired through repurchase program | $ 26,000,000 | ||||||||
Common Stock | October2023 Stock Repurchase Program | Subsequent Event | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Stock repurchase program authorized amount | $ 75,000,000 |
Stockholders_ Equity and Stoc_4
Stockholders’ Equity and Stock-Based Compensation - Restricted Stock Unit Activity (Details) - Equity Incentive Plan - Restricted Stock Units | 9 Months Ended |
Sep. 30, 2023 $ / shares shares | |
Units | |
Beginning balance (in shares) | shares | 2,227,081 |
Awards granted (in shares) | shares | 1,402,715 |
Awards vested (in shares) | shares | (830,549) |
Awards canceled (in shares) | shares | (336,753) |
Ending balance (in shares) | shares | 2,462,494 |
Weighted Average Grant Date Fair Value | |
Beginning balance (in dollars per share) | $ / shares | $ 35.28 |
Awards granted (in dollars per share) | $ / shares | 33.84 |
Awards vested (in dollars per share) | $ / shares | 33.56 |
Awards canceled (in dollars per share) | $ / shares | 30.14 |
Ending balance (in dollars per share) | $ / shares | $ 35.74 |
Stockholders_ Equity and Stoc_5
Stockholders’ Equity and Stock-Based Compensation - ESPP Activity (Details) - Employee stock purchase plan | 9 Months Ended |
Sep. 30, 2023 $ / shares shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Shares issued (in shares) | shares | 363,190 |
Weighted average per share purchase price (in dollars per share) | $ 24.29 |
Weighted average per share discount from the fair value of our common stock on the date of issuance (in dollars per share) | $ 7.65 |
Stockholders_ Equity and Stoc_6
Stockholders’ Equity and Stock-Based Compensation - Stock-Based Compensation (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation | $ 10,839 | $ 7,995 | $ 29,333 | $ 21,873 |
Cost of revenues | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation | 1,376 | 1,022 | 4,801 | 2,834 |
Research and development | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation | 3,173 | 2,027 | 7,908 | 5,708 |
Selling, general and administrative | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation | $ 6,290 | $ 4,946 | $ 16,624 | $ 13,331 |
Stockholders_ Equity and Stoc_7
Stockholders’ Equity and Stock-Based Compensation - Unrecognized Compensation Costs (Details) $ in Thousands | 9 Months Ended |
Sep. 30, 2023 USD ($) | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Unrecognized Expense | $ 75,150 |
Average Expected Recognition Period in Years | 2 years 2 months 1 day |
Restricted stock units | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Unrecognized Expense | $ 58,985 |
Average Expected Recognition Period in Years | 2 years 2 months 15 days |
Performance restricted stock units | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Unrecognized Expense | $ 14,667 |
Average Expected Recognition Period in Years | 2 years 2 months 12 days |
Employee stock purchase plan | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Unrecognized Expense | $ 1,498 |
Average Expected Recognition Period in Years | 3 months |
Net Income per Share (Details)
Net Income per Share (Details) - shares shares in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
Earnings Per Share [Abstract] | ||||
Weighted-average shares used in computing basic net income per share (in shares) | 77,571 | 77,245 | 77,265 | 77,796 |
Add potentially dilutive securities (in shares) | 841 | 443 | 595 | 696 |
Weighted-average shares used in computing diluted net income per share (in shares) | 78,412 | 77,688 | 77,860 | 78,492 |
Securities not included as they would have been antidilutive (in shares) | 172 | 897 | 94 | 266 |
Leases - Narrative (Details)
Leases - Narrative (Details) | Sep. 30, 2023 |
Lessee, Lease, Description [Line Items] | |
Operating lease, renewal term | 20 years |
Operating lease, weighted average remaining lease term | 5 years |
Operating lease, weighted average discount rate | 4.39% |
Minimum | |
Lessee, Lease, Description [Line Items] | |
Operating lease, term of contract | 1 year |
Maximum | |
Lessee, Lease, Description [Line Items] | |
Operating lease, term of contract | 6 years |
Automobiles | |
Lessee, Lease, Description [Line Items] | |
Operating lease, term of contract | 1 year |
Leases - Components of Lease Ex
Leases - Components of Lease Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
Leases [Abstract] | ||||
Operating lease expense | $ 2,157 | $ 2,118 | $ 6,233 | $ 6,522 |
Short-term lease expense | 126 | 135 | 419 | 251 |
Variable lease expense | 625 | 590 | 1,854 | 1,725 |
Total lease expense | $ 2,908 | $ 2,843 | $ 8,506 | $ 8,498 |
Leases - Schedule of Future Min
Leases - Schedule of Future Minimum Payments Under Leases (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Leases [Abstract] | ||
Remainder of 2023 | $ 2,175 | |
2024 | 8,773 | |
2025 | 8,670 | |
2026 | 7,151 | |
2027 | 6,734 | |
Thereafter | 3,541 | |
Total minimum lease payments | 37,044 | |
Less: interest | (3,941) | |
Present value of net minimum lease payments | 33,103 | |
Less: current portion | (8,007) | $ (7,353) |
Total long-term operating lease liabilities | $ 25,096 | $ 27,587 |
Revenue - Additional Informatio
Revenue - Additional Information (Details) - USD ($) $ in Millions | 9 Months Ended | |
Sep. 30, 2023 | Dec. 31, 2022 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Performance obligations | $ 13.8 | |
Contract assets | 2.9 | $ 1.9 |
Contract with customer, liability | 18 | $ 30.9 |
Revenue recognized included in contracts | $ 26 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-02 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Revenue, remaining performance obligation, percentage | 23.20% | |
Revenue, remaining performance obligation, expected timing of satisfaction, period | 3 months | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-12-31 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Revenue, remaining performance obligation, percentage | 66.70% | |
Revenue, remaining performance obligation, expected timing of satisfaction, period | 1 year | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-12-29 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Revenue, remaining performance obligation, percentage | 10.10% | |
Revenue, remaining performance obligation, expected timing of satisfaction, period |
Operating Segments and Enterp_3
Operating Segments and Enterprise-Wide Information - Additional Information (Details) | 9 Months Ended |
Sep. 30, 2023 segment | |
Segment Reporting [Abstract] | |
Number of reportable segments | 2 |
Operating Segments and Enterp_4
Operating Segments and Enterprise-Wide Information - Operating Results by Segment (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
Segment Reporting Information [Line Items] | ||||
Revenues | $ 171,575 | $ 180,869 | $ 494,939 | $ 581,950 |
Gross profit | $ 69,285 | $ 62,213 | $ 190,646 | $ 250,806 |
Gross margin | 40.40% | 34.40% | 38.50% | 43.10% |
Probe Cards | ||||
Segment Reporting Information [Line Items] | ||||
Revenues | $ 128,339 | $ 139,365 | $ 370,970 | $ 467,056 |
Systems | ||||
Segment Reporting Information [Line Items] | ||||
Revenues | 43,236 | 41,504 | 123,969 | 114,894 |
Operating segments | Probe Cards | ||||
Segment Reporting Information [Line Items] | ||||
Revenues | 128,339 | 139,365 | 370,970 | 467,056 |
Gross profit | $ 49,383 | $ 48,252 | $ 135,118 | $ 203,874 |
Gross margin | 38.50% | 34.60% | 36.40% | 43.70% |
Operating segments | Systems | ||||
Segment Reporting Information [Line Items] | ||||
Revenues | $ 43,236 | $ 41,504 | $ 123,969 | $ 114,894 |
Gross profit | $ 22,396 | $ 22,284 | $ 64,266 | $ 59,967 |
Gross margin | 51.80% | 53.70% | 51.80% | 52.20% |
Operating segments | Corporate and Other | ||||
Segment Reporting Information [Line Items] | ||||
Revenues | $ 0 | $ 0 | $ 0 | $ 0 |
Gross profit | $ (2,494) | $ (8,323) | $ (8,738) | $ (13,035) |
Gross margin |
Operating Segments and Enterp_5
Operating Segments and Enterprise-Wide Information - Revenue by Segment, Recognition Type, and Geographic Area (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 24, 2022 | Sep. 30, 2023 | Sep. 24, 2022 | |
Disaggregation of Revenue [Line Items] | ||||
Revenues | $ 171,575 | $ 180,869 | $ 494,939 | $ 581,950 |
Probe Cards | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 128,339 | 139,365 | 370,970 | 467,056 |
Systems | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 43,236 | 41,504 | 123,969 | 114,894 |
Taiwan | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 42,975 | 36,838 | 112,816 | 139,927 |
Taiwan | Probe Cards | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 39,155 | 32,227 | 103,368 | 119,937 |
Taiwan | Systems | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 3,820 | 4,611 | 9,448 | 19,990 |
United States | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 43,725 | 38,089 | 124,129 | 94,978 |
United States | Probe Cards | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 31,182 | 25,909 | 86,954 | 67,424 |
United States | Systems | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 12,543 | 12,180 | 37,175 | 27,554 |
China | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 21,750 | 36,728 | 72,357 | 124,862 |
China | Probe Cards | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 10,779 | 27,973 | 45,771 | 101,342 |
China | Systems | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 10,971 | 8,755 | 26,586 | 23,520 |
South Korea | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 35,075 | 28,937 | 83,713 | 85,193 |
South Korea | Probe Cards | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 31,805 | 28,118 | 77,832 | 80,417 |
South Korea | Systems | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 3,270 | 819 | 5,881 | 4,776 |
Malaysia | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 5,964 | 6,509 | 23,911 | 44,952 |
Malaysia | Probe Cards | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 5,778 | 6,272 | 22,279 | 43,946 |
Malaysia | Systems | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 186 | 237 | 1,632 | 1,006 |
Japan | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 6,964 | 7,692 | 25,873 | 27,011 |
Japan | Probe Cards | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 2,976 | 4,533 | 14,014 | 16,034 |
Japan | Systems | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 3,988 | 3,159 | 11,859 | 10,977 |
Europe | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 9,296 | 11,798 | 29,538 | 28,284 |
Europe | Probe Cards | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 2,583 | 3,682 | 8,424 | 9,888 |
Europe | Systems | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 6,713 | 8,116 | 21,114 | 18,396 |
Singapore | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 3,677 | 10,357 | 11,840 | 28,361 |
Singapore | Probe Cards | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 2,752 | 7,983 | 7,670 | 23,398 |
Singapore | Systems | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 925 | 2,374 | 4,170 | 4,963 |
Rest of the world | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 2,149 | 3,921 | 10,762 | 8,382 |
Rest of the world | Probe Cards | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 1,329 | 2,668 | 4,658 | 4,670 |
Rest of the world | Systems | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 820 | 1,253 | 6,104 | 3,712 |
Products transferred at a point in time | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 169,507 | 176,444 | 485,920 | 570,478 |
Products transferred at a point in time | Probe Cards | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 127,731 | 138,602 | 368,939 | 464,139 |
Products transferred at a point in time | Systems | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 41,776 | 37,842 | 116,981 | 106,339 |
Products and services transferred over time | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 2,068 | 4,425 | 9,019 | 11,472 |
Products and services transferred over time | Probe Cards | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 608 | 763 | 2,031 | 2,917 |
Products and services transferred over time | Systems | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 1,460 | 3,662 | 6,988 | 8,555 |
Foundry & Logic | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 96,366 | 90,605 | 279,895 | 327,106 |
Foundry & Logic | Probe Cards | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 96,366 | 90,605 | 279,895 | 327,106 |
Foundry & Logic | Systems | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 0 | 0 | 0 | 0 |
DRAM | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 27,478 | 34,922 | 77,832 | 106,202 |
DRAM | Probe Cards | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 27,478 | 34,922 | 77,832 | 106,202 |
DRAM | Systems | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 0 | 0 | 0 | 0 |
Flash | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 4,495 | 13,838 | 13,243 | 33,748 |
Flash | Probe Cards | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 4,495 | 13,838 | 13,243 | 33,748 |
Flash | Systems | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 0 | 0 | 0 | 0 |
Systems | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 43,236 | 41,504 | 123,969 | 114,894 |
Systems | Probe Cards | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | 0 | 0 | 0 | 0 |
Systems | Systems | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenues | $ 43,236 | $ 41,504 | $ 123,969 | $ 114,894 |
Uncategorized Items - form-2023
Label | Element | Value |
Increase (Decrease) in Deferred Government Grant | form_IncreaseDecreaseInDeferredGovernmentGrant | $ 0 |